Topics

Assessing recent approvals in bladder cancer

11:33 EST 16 Jan 2020 | Pharmaceutical Technology

On December 18 2019, the FDA granted accelerated approval for Seattle Genetic/Astellas Pharmaceutical’s Padcev (enfortumab vedotin-ejfv). Merck and Co’s Keytruda...
Read More...

The post Assessing recent approvals in bladder cancer appeared first on Pharmaceutical Technology.

Original Article: Assessing recent approvals in bladder cancer

NEXT ARTICLE

More From BioPortfolio on "Assessing recent approvals in bladder cancer"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...